ARKG - ARK Genomic Revolution ETF contains 35 holdings. The top holdings include CRSP, TEM, TWST, GH, RXRX
Name | Weight |
---|---|
10.92% | |
8.27% | |
7.44% | |
6.20% | |
5.82% | |
![]() | 4.87% |
![]() | 4.53% |
4.16% | |
4.11% | |
![]() | 3.91% |
3.86% | |
3.74% | |
3.25% | |
3.17% | |
![]() | 2.92% |
![]() | 2.39% |
![]() | 2.39% |
2.27% | |
1.80% | |
![]() | 1.56% |
1.50% | |
1.44% | |
1.27% | |
1.25% | |
1.13% | |
1.01% | |
![]() | 0.95% |
![]() | 0.94% |
0.92% | |
0.63% |
Sector | Weight |
---|---|
Health Care | 98.52% |
Information Technology | 1.44% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -27.74% | $24.35B | +37.95% | 1.09% |
ED | -20.53% | $35.78B | +11.77% | 3.38% |
CME | -17.47% | $99.33B | +45.14% | 1.75% |
MO | -15.88% | $100.29B | +27.49% | 6.88% |
AWK | -14.65% | $27.50B | +7.88% | 2.23% |
DUK | -13.26% | $90.40B | +15.23% | 3.60% |
EXC | -10.90% | $43.41B | +24.89% | 3.62% |
T | -10.53% | $203.56B | +50.48% | 3.92% |
AEP | -9.10% | $55.53B | +18.55% | 3.53% |
KMB | -9.02% | $43.60B | -5.76% | 3.77% |
SO | -8.78% | $100.30B | +16.82% | 3.18% |
KR | -8.58% | $46.11B | +34.48% | 1.84% |
CL | -8.13% | $74.67B | -5.05% | 2.19% |
LITB | -7.45% | $23.17M | -74.54% | 0.00% |
AMT | -7.16% | $103.32B | +12.63% | 3.03% |
K | -6.64% | $27.53B | +40.77% | 2.87% |
TEF | -6.53% | $29.46B | +22.82% | 6.25% |
VZ | -5.85% | $181.55B | +4.26% | 6.29% |
MKTX | -5.52% | $8.13B | +6.08% | 1.38% |
MCK | -5.08% | $90.44B | +23.40% | 0.39% |
Name | Correlation | AUM | Expense Ratio | |
---|---|---|---|---|
GNOM | 90.03% | $46.32M | 0.5% | |
XBI | 83.32% | $4.90B | 0.35% | |
ARKK | 81.77% | $6.84B | 0.75% | |
IWO | 81.76% | $11.87B | 0.24% | |
IWC | 81.21% | $847.74M | 0.6% | |
KOMP | 79.88% | $2.35B | 0.2% | |
VBK | 79.16% | $19.31B | 0.07% | |
IWM | 79.01% | $66.85B | 0.19% | |
VTWO | 78.95% | $12.85B | 0.07% | |
ISCG | 78.41% | $694.97M | 0.06% | |
PBE | 78.05% | $228.63M | 0.58% | |
SCHA | 77.93% | $17.76B | 0.04% | |
IBB | 77.82% | $5.44B | 0.45% | |
VXF | 77.46% | $23.67B | 0.05% | |
KJAN | 77.18% | $287.30M | 0.79% | |
KJUL | 77.15% | $153.16M | 0.79% | |
QQQJ | 77.14% | $630.82M | 0.15% | |
NUSC | 76.96% | $1.17B | 0.31% | |
ESML | 76.81% | $1.90B | 0.17% | |
SMMD | 76.42% | $1.49B | 0.15% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
RXRX | 81.34% | $2.18B | -27.96% | 0.00% |
CRSP | 79.45% | $4.73B | -0.38% | 0.00% |
TWST | 77.51% | $2.22B | -26.77% | 0.00% |
BEAM | 77.44% | $2.04B | -14.85% | 0.00% |
TXG | 68.95% | $1.53B | -32.88% | 0.00% |
DNLI | 67.52% | $2.08B | -31.63% | 0.00% |
ABCL | 67.40% | $1.16B | +37.94% | 0.00% |
NTLA | 67.10% | $1.15B | -50.04% | 0.00% |
SDGR | 66.59% | $1.57B | +4.44% | 0.00% |
TEM | 66.39% | $10.13B | +69.59% | 0.00% |
CERS | 66.18% | $279.09M | -26.26% | 0.00% |
BN | 66.13% | $103.50B | +46.08% | 0.54% |
BNT | 65.77% | $12.62B | +46.50% | 0.00% |
KN | 65.53% | $1.57B | +3.26% | 0.00% |
ADPT | 65.51% | $1.78B | +231.64% | 0.00% |
COHU | 65.32% | $951.45M | -41.22% | 0.00% |
AEIS | 64.95% | $5.20B | +28.88% | 0.29% |
ITT | 64.92% | $12.41B | +25.16% | 0.84% |
TECH | 64.61% | $8.26B | -26.10% | 0.61% |
SOFI | 64.47% | $22.05B | +212.70% | 0.00% |
Name | Correlation | AUM | Expense Ratio | |
---|---|---|---|---|
BILZ | -0.03% | $861.77M | 0.14% | |
YEAR | 0.06% | $1.47B | 0.25% | |
BWX | -0.11% | $1.53B | 0.35% | |
SMB | -0.12% | $274.58M | 0.07% | |
CANE | 0.30% | $11.26M | 0.29% | |
IBTP | -0.61% | $142.32M | 0.07% | |
XBIL | 0.61% | $784.40M | 0.15% | |
AGZD | -0.64% | $98.49M | 0.23% | |
UDN | 0.67% | $147.89M | 0.78% | |
GVI | -0.76% | $3.39B | 0.2% | |
SMMU | -0.77% | $891.96M | 0.35% | |
JMST | -0.78% | $4.08B | 0.18% | |
KCCA | -0.88% | $108.82M | 0.87% | |
IBTF | 0.95% | $1.98B | 0.07% | |
UUP | -0.96% | $198.33M | 0.77% | |
USTB | 1.03% | $1.30B | 0.35% | |
TIPX | 1.44% | $1.73B | 0.15% | |
OWNS | 1.45% | $128.62M | 0.3% | |
TDTF | 1.62% | $832.57M | 0.18% | |
BNDX | 1.62% | $67.61B | 0.07% |
Name | Correlation | AUM | Expense Ratio | |
---|---|---|---|---|
BTAL | -66.74% | $312.42M | 1.43% | |
VIXY | -57.58% | $185.99M | 0.85% | |
TAIL | -55.12% | $95.09M | 0.59% | |
IVOL | -33.33% | $342.02M | 1.02% | |
SPTS | -22.52% | $5.77B | 0.03% | |
XONE | -22.03% | $627.68M | 0.03% | |
ULST | -19.46% | $595.49M | 0.2% | |
FTSD | -19.21% | $233.04M | 0.25% | |
UTWO | -18.36% | $376.38M | 0.15% | |
FXY | -17.87% | $812.67M | 0.4% | |
IBTG | -17.54% | $1.92B | 0.07% | |
VGSH | -17.15% | $22.64B | 0.03% | |
SHYM | -16.73% | $355.63M | 0.35% | |
SCHO | -16.53% | $11.00B | 0.03% | |
STPZ | -15.86% | $443.02M | 0.2% | |
LDUR | -15.75% | $922.21M | 0.5% | |
IBTH | -15.54% | $1.61B | 0.07% | |
IBTI | -13.47% | $1.06B | 0.07% | |
BSMW | -13.12% | $107.54M | 0.18% | |
XHLF | -12.51% | $1.73B | 0.03% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
MSIF | -0.04% | $777.96M | +37.67% | 7.52% |
FE | 0.06% | $23.02B | +3.21% | 4.32% |
AQB | -0.07% | $3.01M | -53.91% | 0.00% |
GIS | -0.08% | $28.12B | -17.31% | 4.64% |
VSTA | -0.10% | $332.04M | +38.00% | 0.00% |
ZCMD | 0.10% | $30.81M | +2.52% | 0.00% |
BTCT | -0.24% | $25.33M | +62.02% | 0.00% |
HSY | 0.30% | $34.43B | -7.01% | 3.25% |
MDLZ | -0.31% | $88.29B | +4.52% | 2.77% |
GFI | 0.51% | $20.91B | +50.71% | 2.38% |
PULM | -0.52% | $23.96M | +218.45% | 0.00% |
FDP | 0.54% | $1.58B | +55.34% | 3.32% |
CCEC | 0.58% | $1.02B | +3.91% | 2.56% |
CMS | -0.59% | $20.75B | +17.86% | 3.05% |
WTRG | -0.62% | $10.40B | -0.30% | 3.52% |
WEC | 0.83% | $33.08B | +32.88% | 3.34% |
BTI | 0.95% | $104.90B | +50.87% | 6.18% |
CAG | 0.98% | $9.86B | -28.15% | 6.76% |
CNC | 1.00% | $16.22B | -50.41% | 0.00% |
DG | 1.10% | $24.80B | -12.33% | 2.62% |
SeekingAlpha
With high-growth companies consistently delivering superior profit margins, the traditional tradeoff between growth and value may now be irrelevant.
SeekingAlpha
Who Will Benefit From Deregulation?
SeekingAlpha
Healthcare has been a tough sector in 2025. It looks like Q2 could be the low point for healthcare earnings growth for this year, but the sector is being buffeted by a number of headwinds.
SeekingAlpha
Pacific Biosciences of California faces steep stock decline and financial challenges. Click here to see why PACB stock is a Sell.
SeekingAlpha
3 Areas Of Focus As U.S. Earnings Strength Continues
SeekingAlpha
The U.S. is proposing major policy changes to its healthcare sector, including imposing tariffs on global manufacturers. Click to read.